Search
for
Sort by
Research 181–210 of 789
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- XMU-MP-1 induces growth arrest in a model human mini-organ and antagonises cell cycle-dependent paclitaxel cytotoxicity
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Type 2 innate immunity regulates hair follicle homeostasis to control <i>Demodex</i> pathosymbionts
- Janus Kinase inhibitors in dermatology: a review
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm